These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24261471)

  • 61. Design of validation studies for estimating the odds ratio of exposure-disease relationships when exposure is misclassified.
    Holcroft CA; Spiegelman D
    Biometrics; 1999 Dec; 55(4):1193-201. PubMed ID: 11315067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. On latent-variable model misspecification in structural measurement error models for binary response.
    Huang X; Tebbs JM
    Biometrics; 2009 Sep; 65(3):710-8. PubMed ID: 18945265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Measurement error model for misclassified binary responses.
    Roy S; Banerjee T; Maiti T
    Stat Med; 2005 Jan; 24(2):269-83. PubMed ID: 15546132
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities.
    Ezzalfani M; Zohar S; Qin R; Mandrekar SJ; Deley MC
    Stat Med; 2013 Jul; 32(16):2728-46. PubMed ID: 23335156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bias reduction in logistic dose-response models.
    Wagler A
    J Biopharm Stat; 2011 May; 21(3):405-22. PubMed ID: 21442516
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying multiple change points in a linear mixed effects model.
    Lai Y; Albert PS
    Stat Med; 2014 Mar; 33(6):1015-28. PubMed ID: 24114935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An evaluation of population D-optimal designs via pharmacokinetic simulations.
    Hooker AC; Foracchia M; Dodds MG; Vicini P
    Ann Biomed Eng; 2003 Jan; 31(1):98-111. PubMed ID: 12572660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bayesian analysis of time-series data under case-crossover designs: posterior equivalence and inference.
    Li S; Mukherjee B; Batterman S; Ghosh M
    Biometrics; 2013 Dec; 69(4):925-36. PubMed ID: 24289144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficient Standard Error Formulas of Ability Estimators with Dichotomous Item Response Models.
    Magis D
    Psychometrika; 2016 Mar; 81(1):184-200. PubMed ID: 25691364
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Likelihood-Based Random-Effect Meta-Analysis of Binary Events.
    Amatya A; Bhaumik DK; Normand SL; Greenhouse J; Kaizar E; Neelon B; Gibbons RD
    J Biopharm Stat; 2015; 25(5):984-1004. PubMed ID: 24918874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
    Kurland BF; Doot RK; Linden HM; Mankoff DA; Kinahan PE
    Clin Trials; 2013; 10(6):886-95. PubMed ID: 24169628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimal sampling strategies for two-stage studies.
    Reilly M
    Am J Epidemiol; 1996 Jan; 143(1):92-100. PubMed ID: 8533752
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimation and testing based on data subject to measurement errors: from parametric to non-parametric likelihood methods.
    Vexler A; Tsai WM; Malinovsky Y
    Stat Med; 2012 Sep; 31(22):2498-512. PubMed ID: 21805485
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simple confidence interval and region formulas for comparing diagnostic likelihood ratios under a paired design.
    Wu Y
    Biom J; 2021 Jun; 63(5):1086-1095. PubMed ID: 33738853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Controlling for seasonal patterns and time varying confounders in time-series epidemiological models: a simulation study.
    Perrakis K; Gryparis A; Schwartz J; Le Tertre A; Katsouyanni K; Forastiere F; Stafoggia M; Samoli E
    Stat Med; 2014 Dec; 33(28):4904-18. PubMed ID: 25052462
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Accounting for nonignorable verification bias in assessment of diagnostic tests.
    Kosinski AS; Barnhart HX
    Biometrics; 2003 Mar; 59(1):163-71. PubMed ID: 12762453
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeted maximum likelihood estimation in safety analysis.
    Lendle SD; Fireman B; van der Laan MJ
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S91-8. PubMed ID: 23849159
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
    Manchon P; Belhadi D; Mentré F; Laouénan C
    BMC Med Res Methodol; 2021 May; 21(1):98. PubMed ID: 33952195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Point estimation in adaptive enrichment designs.
    Kunzmann K; Benner L; Kieser M
    Stat Med; 2017 Nov; 36(25):3935-3947. PubMed ID: 28783881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.